Mark Van Oene
Illumina has named Mark Van Oene chief commercial officer. He will be responsible for worldwide sales, services, and marketing and will report to CEO Francis deSouza. Van Oene previously served as Illumina's senior vice president of the Americas region and has served as interim CCO since late 2016. He joined Illumina in 2006 as regional account manager for Canada.
Saturnino Fanlo
Human Longevity has appointed Saturnino Fanlo as CFO. Fanlo will report to CEO Cynthia Collins. He joins Human Longevity from Social Finance (SoFi), where he served as president and CFO. Prior to SoFi, Fanlo held a series of high level leadership roles in various financial firms, including senior advisor at Golden Gate Capital, CEO at KKR Financial, chief information officer at KKR Asset Management, and executive VP and treasurer at Wells Fargo. He has also held positions with Goldman Sachs, Australian Capital Equity, and First Boston Corporation.
Andrea Califano
Tempus has appointed Andrea Califano to its scientific advisory board. Califano serves as the Clyde and Helen Wu Professor of Chemical Systems Biology at Columbia University Medical Center. He is also the founding chair of the department of systems biology, director of the JP Sulzberger Columbia Genome Center, and associate director for bioinformatics at the Herbert Irving Comprehensive Cancer Center. Additionally, he holds appointments in the department of biochemistry and molecular biophysics and the department of biomedical informatics.
For more recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.